Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients: Journal of Neuro-Oncology

M. Massimino, M.P. Sunyach, F. Barretta, L. Gandola, A. Garegnani, E. Pecori, F. Spreafico, A. Bonneville-Levard, D. Meyronet, C. Mottolese, L. Boschetti, V. Biassoni, E. Schiavello, C. Giussani, G. Carrabba, B. Diletto, F. Pallotti, R. Stefini, A. Ferrari, M. TerenzianiM. Casanova, R. Luksch, C. Meazza, M. Podda, S. Chiaravalli, N. Puma, L. Bergamaschi, C. Morosi, G. Calareso, F. Giangaspero, M. Antonelli, F.R. Buttarelli, D. Frappaz

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)619-628
JournalJ. Neuro-Oncol.
Volume148
Issue number3
DOIs
Publication statusPublished - 2020

Keywords

  • Adult medulloblastoma
  • Chemotherapy
  • Craniospinal irradiation
  • Side-effects

Cite this

Massimino, M., Sunyach, M. P., Barretta, F., Gandola, L., Garegnani, A., Pecori, E., Spreafico, F., Bonneville-Levard, A., Meyronet, D., Mottolese, C., Boschetti, L., Biassoni, V., Schiavello, E., Giussani, C., Carrabba, G., Diletto, B., Pallotti, F., Stefini, R., Ferrari, A., ... Frappaz, D. (2020). Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients: Journal of Neuro-Oncology. J. Neuro-Oncol., 148(3), 619-628. https://doi.org/10.1007/s11060-020-03564-y